First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignancies.

Saved in:
Bibliographic Details
Title: First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignancies.
Authors: Ilan U; Princess Máxima Center for Pediatric Oncology, Utrecht., Boer JM; Princess Máxima Center for Pediatric Oncology, Utrecht., Luesink M; Princess Máxima Center for Pediatric Oncology, Utrecht., Bautista F; Princess Máxima Center for Pediatric Oncology, Utrecht., Hofmans M; Department of Laboratory Medicine, Ghent University Hospital, Ghent., Vedi A; Cambridge University Hospitals NHS Foundation Trust, Cambridge., Egyed B; Department of Pediatrics, Semmelweis University, Budapest., Geoerger B; Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, INSERM U1015, Université Paris-Saclay, Villejuif., Tuckuviene R; Department of Pediatrics, Aalborg University Hospital, Aalborg., Als-Nielsen B; Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen., Velasco P; Pediatric Oncology and Hematology Department, Hospital Vall d'Hebrón, Barcelona., Fuster JL; Sección de Oncohematología Pediátrica, Hospital Virgen de Arrixaca, Murcia., Rubio A; Pediatric Oncology and Hematology Department, Hospital Infantil Universitario Niño Jesús, Madrid., Tasian SK; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Children's Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research; Philadelphia, Pennsylvania, USA; University of Pennsylvania School of Medicine, Department of Pediatrics; Philadelphia, Pennsylvania., Delft FV; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne., Irving JAE; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne., Erdély DJ; Department of Pediatrics, Semmelweis University, Budapest., Schmiegelow K; Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen., De Moerloose B; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent., Baruchel A; University Hospital Robert Debré (APHP) and Université de Paris, Paris., Den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht. m.l.denboer@prinsesmaximacentrum.nl., Zwaan MC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam. c.m.zwaan-2@prinsesmaximacentrum.nl.
Source: Haematologica [Haematologica] 2026 Apr 02. Date of Electronic Publication: 2026 Apr 02.
Publication Type: Journal Article
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1592-8721
DOI:10.3324/haematol.2025.300154